Cargando…
The efficacy and safety of glucokinase activators for the treatment of type-2 diabetes mellitus: A protocol for systematic review and meta-analysis
BACKGROUND: Glucokinase activators are a novel family of glucose-lowering agents used for the treatment of type-2 diabetes mellitus (T2DM). Glucokinase activators blind to GK activate the enzyme allosterically. Treatment with different GKAs has been shown to reduce fasting and postprandial glucose i...
Autores principales: | Gao, Qian, Zhang, Wenjun, Li, Tingting, Yang, Guojun, Zhu, Wei, Chen, Naijun, Jin, Huawei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7899907/ https://www.ncbi.nlm.nih.gov/pubmed/33607862 http://dx.doi.org/10.1097/MD.0000000000024873 |
Ejemplares similares
-
The efficacy and safety of glucokinase activators for the treatment of type-2 diabetes mellitus: A meta-analysis
por: Gao, Qian, et al.
Publicado: (2021) -
Efficacy and safety of sotagliflozin adjuvant therapy for type 1 diabetes mellitus: A systematic review and meta-analysis
por: Chen, Mao-Bing, et al.
Publicado: (2020) -
Effectiveness and safety of sotagliflozin adjuvant therapy for type 1 diabetes mellitus: A protocol for Systematic review and Meta-analysis
por: Chen, Mao-Bing, et al.
Publicado: (2019) -
Efficacy and safety of once-weekly semaglutide for the treatment of type 2 diabetes: Protocol for a systematic review and meta-analysis
por: Shi, Fang-Hong, et al.
Publicado: (2018) -
The efficacy and safety of acupoint injection for diabetic gastroparesis: A protocol for systematic review and meta-analysis
por: Long, Tao, et al.
Publicado: (2020)